Collagen Crosslinks and Biochemical Markers of Bone Turnover – Commercial and Individual Exchange Medical Policyopen_in_new

UnitedHealthcare deems serum or urine collagen crosslinks and biochemical markers of bone turnover unproven and not medically necessary — excluded for assessing fracture risk, predicting bone loss, or monitoring response to antiresorptive therapy. Coverage is not routinely provided and no specific documentation checklist exists; coverage decisions follow the member-specific benefit plan and applicable laws, and any claims must be supported by medical records showing medical necessity (FDA clearance alone does not ensure coverage).

"None — Serum or urine collagen crosslinks or biochemical markers of bone turnover are considered unproven and NOT medically necessary for: assessing risk of fracture, predicting bone loss, or asses..."

Sign up to see full coverage criteria, indications, and limitations.